Press release
Comprehensive Report on Topical Drug Delivery Market Set to Witness Huge Growth by 2026 | Skinvisible Pharmaceuticals, Inc., Mylan N.V., Pocono Coated Products LLC, Lohmann Therapie-Systeme AG
Topical Drug Delivery Market
Get Sample PDF Copy (Including COVID-19 Impact Analysis, full TOC, Tables, and Figures) of Topical Drug Delivery Market Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-topical-drug-delivery-market
Key Players
Galderma S.A. (Switzerland),
GlaxoSmithKline plc. (U.K.),
Valeant Pharmaceuticals International, Inc. (Canada),
Crescita Therapeutics Inc. (Canada),
Medpharm (U.K.),
3M (U.S.),
Bayer AG (Germany),
Novartis AG (Switzerland),
Janssen Global Services, LLC (U.S.),
Cipla Inc. (India),
West Pharmaceutical Services ,Inc (US),
Biofarmitalia s.r.l (Italy),
Pharmatek Laboratories, Inc. (US),
Stiefel Laboratories, Inc. (US),
Tapemark (US),
Acrux Limited (Australia),
Nitto Denko Corporation (Japan),
Skinvisible Pharmaceuticals, Inc. (us),
Mylan N.V. (US),
Pocono Coated Products LLC (US),
Lohmann Therapie-Systeme AG (Germany).
Global Topical Drug Delivery Market is expected to rise from its initial estimated value of USD 120.82 billion in 2018 to an estimated value of USD 240.76 billion by 2026, registering a CAGR of 9.00% in the forecast period of 2019-2026.
Topical drug delivery is one of the most effective ways of drug delivery as it gives optimum therapeutic outcomes. Gradually, the topical drug delivery system has become increasingly important in the pharmaceutical industry. The pharmacological response, both the desired therapeutic effect and the undesired unfavourable effect of a drug is dependent on the concentration of the drug at the place of action, which in turn depends upon the dosage form and the extent of absorption of the drug at the site of action.
According to World Health Organization, there were an estimated 9.6 million deaths in 2018 due to cancer; Cancer is the second leading cause of death globally. About 1 in 6 deaths is due to cancer. These deaths could have been avoided with the availability of proper medical for healthcare procedures. This significant number is expected to act as a driver to the market growth
Market Drivers
There is high demand for prevalence of skin diseases is expected to act as a driver to the market growth
High growing preference for topical drug delivery is also expected to act as a driver to the market growth
There is increase in incidence of burn injuries is also expected to act as a driver to the market growth
Rising incidence of diabetes is also to drive the market
Market Restraints
Negative impact of product recalls is expected to restrain the market growth.
Segmentation: Global Topical Drug Delivery Market
By Product Type
Topical
Solid Topical Formulations
Suppositories
Powders
Semi-Solid Topical Formulations
Creams
Gels
Ointments
Pastes
Lotions
Liquid Topical Formulations
Solutions
Suspensions
Transdermal
Patches
Gels
By Application of Drug
Skin Drug
Ophthalmic Drug
Rectal Drug
Vaginal Drug
Nasal Drug
By End User
Hospitals and Private Clinics
Home Care Settings
Other
By Distribution Channel
Direct Tenders
Retail
By Geography
North America
South America
Europe
Asia-Pacific
Middle East & Africa
Inquiry Before Buying @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-topical-drug-delivery-market
Key Developments in the Market:
In December 2018,Aclaris Therapeutics Acquired RHOFADE® from Allergan. RHOFADE cream was approved by the U.S. Food and Drug Administration (FDA) in 2017 for the topical treatment of persistent facial erythema (redness) associated with rosacea in adults. By this acquisition Aclaris to further strengthen itself in topical treatments.
In December 2018, Sun Pharma acquires Pola Pharma's two manufacturing plants. Pola Pharma is a topical drug and injectables manufacture in Japan. By this acquisition sun Pharma to further strengthen its presence in Japan.
Competitive Analysis: Global Topical Drug Delivery Market
Global topical drug delivery market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of topical drug delivery market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Reasons to Purchase this Report
Current and future of global topical drug delivery market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Table of Contents:
INTRODUCTION
1.1. OVERVIEW OF GLOBAL TOPICAL DRUG DELIVERY MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
MARKET OVERVIEW
3.1. DRIVERS
3.1.1. RISING CASES OF ACUTE AND CHRONIC DISEASE
3.1.2. RISING AGING POPULATION
3.1.3. TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS
3.1.4. APPROVAL OF NEW DRUGS
3.1.5. BETTER OPPORTUNITY IN PHARMERGING MARKETS
3.2. RESTRAINTS
3.2.1. REGULATORY SCENARIO AND PRICING PRESSURE
3.3. OPPORTUNITY
3.3.1. ENERGING MARKET
3.3.2. RISING ACCEPTANCE FOR SELF-ADMINISTRATION OF DRUGS
3.4. CHALLENGES
3.4.1. PRODUCT RECALL
3.4.2. PENETRATION INTO THE SMALLER MARKETS
PREMIUM INSIGHTS
EXECUTIVE SUMMARY
GLOBAL TOPICAL DRUG DELIVERY MARKET, BY TYPE
6.1. OVERVIEW
6.2. TRANSDERMAL DRUG DELIVERY SYSTEMS (TDDS)
6.3. TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.4. LIQUID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.5. SEMI SOLID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.6. SOLID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
GLOBAL TOPICAL DRUG DELIVERY MARKET, BY INDICATION
7.1. OVERVIEW
7.2. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY INDICATION
7.3. GLOBAL ANTI-INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION
GLOBAL TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
GLOBAL TOPICAL DRUG DELIVERY MARKET, BY END USER
9.1. OVERVIEW
GLOBAL TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY
10.1. OVERVIEW
10.2. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET
10.2.1. U.S. TOPICAL DRUG DELIVERY MARKET
10.2.2. CANADA TOPICAL DRUG DELIVERY MARKET
10.2.3. MEXICO TOPICAL DRUG DELIVERY MARKET
10.3. EUROPE TOPICAL DRUG DELIVERY MARKET
10.3.1. GERMANY TOPICAL DRUG DELIVERY MARKET
10.3.2. FRANCE TOPICAL DRUG DELIVERY MARKET
10.3.3. ITALY TOPICAL DRUG DELIVERY MARKET
10.3.4. U.K. TOPICAL DRUG DELIVERY MARKET
10.3.5. SWITZERLAND TOPICAL DRUG DELIVERY MARKET
10.3.6. SPAIN TOPICAL DRUG DELIVERY MARKET
10.3.7. NETHERLAND TOPICAL DRUG DELIVERY MARKET
10.3.8. RUSSIA TOPICAL DRUG DELIVERY MARKET
10.3.9. TURKEY TOPICAL DRUG DELIVERY MARKET
10.3.10. BELGIUM TOPICAL DRUG DELIVERY MARKET
10.3.11. REST OF EUROPE TOPICAL DRUG DELIVERY MARKET
10.4. APAC TOPICAL DRUG DELIVERY MARKET
10.4.1. JAPAN TOPICAL DRUG DELIVERY MARKET
10.4.2. CHINA TOPICAL DRUG DELIVERY MARKET
10.4.3. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET
10.4.4. INDIA TOPICAL DRUG DELIVERY MARKET
10.4.5. AUSTRALIA TOPICAL DRUG DELIVERY MARKET
10.4.6. SINGAPORE TOPICAL DRUG DELIVERY MARKET
10.4.7. THAILAND TOPICAL DRUG DELIVERY MARKET
10.4.8. MALAYSIA TOPICAL DRUG DELIVERY MARKET
10.4.9. INDONESIA TOPICAL DRUG DELIVERY MARKET
10.4.10. PHILIPPINES TOPICAL DRUG DELIVERY MARKET
10.4.11. REST OF APAC TOPICAL DRUG DELIVERY MARKET
10.5. SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET
10.5.1. BRAZIL TOPICAL DRUG DELIVERY MARKET
10.5.2. REST OF SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET
10.6. MIDDLE EAST AND AFRICA (MEA) TOPICAL DRUG DELIVERY MARKET
10.6.1. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET
10.6.2. REST OF MEA TOPICAL DRUG DELIVERY MARKET
GLOBAL TOPICAL DRUG DELIVERY MARKET, COMPANY SHARE
11.1. COMPANY SHARE ANALYSIS: GLOBAL
COMPANY PROFILES
Request for Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-topical-drug-delivery-market
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com
About Data Bridge Market Research
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Comprehensive Report on Topical Drug Delivery Market Set to Witness Huge Growth by 2026 | Skinvisible Pharmaceuticals, Inc., Mylan N.V., Pocono Coated Products LLC, Lohmann Therapie-Systeme AG here
News-ID: 2031536 • Views: …
More Releases from Data Bridge Market Research
Vitamin K Market IS growing at a CAGR of 6.8% during the forecast period of 2023 …
Vitamin K Market Analysis and Size
The essential factors contributing to the growth of the market in the forecast period of 2023 to 2020 include growing demand for vitamin supplements, changing dietary patterns, and rising health consciousness.
Data Bridge Market Research analyses that the global vitamin K market, which was USD 841.47 million in 2022, is expected to reach USD 1,410.20 million by 2030, growing at a CAGR of 6.8% during the…
Transformer Oil Market is expected to undergo a CAGR of 7.55% by 2029
Transformer Oil Market Analysis and Size
Transformers are almost everywhere, and every power and distribution transformer is filled with the dielectric insulating fluid, which consists high resistance to electricity and cools the transformer. The "bio based oil" is the highest growing type segment because it has better resistance to fire as compared to other oil over the forecast period. Furthermore, the growth of electric grids in developing economies and the upgradation…
 Fatty Alcohols Market is expected to undergo a CAGR of 5.15% by 2029
Fatty Alcohols Market Analysis and Size
The rising demand of hygiene product coupled with growing consumer awareness is anticipated to drive the personal care industry and boost the growth of the fatty alcohols market. Fatty alcohols are used as emollients, emulsifiers and catalytic hydrogenation in cosmetics and beauty products. The "C11-C14 fatty alcohols" is the fastest growing product segment because it is used to produce sodium laureth ether sulphate (SLES), a major foaming agent…
Exclusive Insights on Gusseted Bags Market Latest Trends, Drivers, Strategies an …
An important Gusseted Bags Market research report is produced by taking into account every requirement that organizations need to meet in order to expand successfully. This market report forecasts the market size based on data on major retailer sales, industry growth by upstream and downstream factors, industry advancement, major players, market segments, and application. When creating the reliable Gusseted Bags Market study, the goals of the marketing research are taken into…
More Releases for DRUG
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.Â
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
